Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
JAMA Dermatology|December 8, 2017
Association of Immunotherapy With Overall Survival in Elderly Patients With MelanomaMarie Perier-Muzet, Elodie Gatt, Julien Péron, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 23, 2022
Benefit from adjuvant radiotherapy according to the number of risk factors in cutaneous squamous cell carcinomaAdeline Pêtre, Pascal Pommier, Tristan Brahmi, et al.
European Journal of Medical Genetics|March 3, 2023
French cohort of children and adolescents with neurofibromatosis type 1 and symptomatic inoperable plexiform neurofibromas: CASSIOPEA studyPierre Wolkenstein, Yves Chaix, Natacha Entz Werle, et al.
Dermatology Practical & Conceptual|July 10, 2020
Diagnostic Concordance in Tertiary (Dermatologists-to-Experts) Teledermoscopy: A Final Diagnosis-Based Study on 290 CasesAnne Marchetti, Stephane Dalle, Delphine Maucort-Boulch, et al.
Cancer Chemotherapy and Pharmacology|April 12, 2017
Adjunction of a MEK inhibitor to Vemurafenib in the treatment of metastatic melanoma results in a 60% reduction of acute kidney injuryCécile Teuma, Solenne Pelletier, Mona Amini-Adl, et al.
International Journal of Molecular Sciences|September 28, 2021
How Are Epigenetic Modifications Related to Cardiovascular Disease in Older Adults?Mojgan Gharipour, Arya Mani, Mona Amini Baghbahadorani, et al.
JAMA Dermatology|June 3, 2026
Limits of Artificial Intelligence Models for Skin Cancer Diagnosis in Realistic SettingsJulien Anriot, Siyuan Yan, Clio Coste, et al.
Cancer Chemotherapy and Pharmacology|July 3, 2016
New insights into renal toxicity of the B-RAF inhibitor, vemurafenib, in patients with metastatic melanomaCécile Teuma, Marie Perier-Muzet, Solenne Pelletier, et al.
Bulletin Du Cancer|April 27, 2021
[Rheumatic immune adverse events related to immune checkpoint inhibitors-(IrAEs related to ICI)]Thomas Tingry, Emmanuel Massy, Muriel Piperno, et al.
European Journal of Cancer (Oxford, England : 1990)|July 13, 2026
Clinical determinants, diagnostic complexity, and molecular heterogeneity in NF1-associated and sporadic malignant peripheral nerve sheath tumors: A 25-year referral-center cohortClio Coste, Mehdi Brahmi, Franck Tirode, et al.
Pageof 4